News >

Organ Preservation Approaches in Muscle-Invasive Bladder Cancer

Angelica Welch
Published: Tuesday, Feb 06, 2018

Amy N. Solan, MD

Amy N. Solan, MD
Selective bladder preservation has been suggested as a potential alternative to cystectomy in patients with bladder cancer who have a transitional cell carcinoma pathology. The goal is to improve long-term quality of life without compromising oncologic outcomes, according to Amy N. Solan, MD, a clinical instructor in the Department of Radiation Oncology at NYU Langone Heath.

 
The current standard treatment for muscle-invasive bladder cancer is radical cystectomy with bilateral pelvic lymphadenectomy, with the addition of neoadjuvant cisplatin-based combination chemotherapy.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x